EP. 1: Adoption of Biosimilars in the United States and Europe
EP. 2: Delivery Systems and the Acceptance of Biosimilars
EP. 3: Cost and Biosimilar Uptake for Oncology
EP. 4: Biosimilar Prescribing and Cost in Rheumatology
EP. 5: Prescribing Behaviors and Biosimilar Substitution
EP. 6: Chronic Therapy and Switching
EP. 7: Physician Understanding of Biologic Manufacturing
EP. 8: Clinical Trial Design With Biosimilars
EP. 9: Post-Market Pharmacovigilance
EP. 10: Patient Awareness of Biosimilar Products
EP. 11: Payer Intervention and Biosimilar Switching
EP. 12: Extrapolation of Indications in Biosimilars
EP. 13: Cost and Biosimilars in Oncology
EP. 14: Competition and Cost for Biosimilars
EP. 15: Cost, Patient Programs, and Access to Biosimilars
EP. 16: Naming and Coding of Biosimilars
EP. 17: State Legislation on Biosimilars and Substitution
EP. 18: Biosimilars in the Next 5 Years
